These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15857121)

  • 1. Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor.
    Grieco P; Giusti L; Carotenuto A; Campiglia P; Calderone V; Lama T; Gomez-Monterrey I; Tartaro G; Mazzoni MR; Novellino E
    J Med Chem; 2005 May; 48(9):3153-63. PubMed ID: 15857121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and conformational studies of [Val4]morphiceptin and [D-Val4]morphiceptin analogs incorporating cis-2-aminocyclopentane carboxylic acid as a peptidomimetic for proline.
    Yamazaki T; Pröbsti A; Schiller PW; Goodman M
    Int J Pept Protein Res; 1991 May; 37(5):364-81. PubMed ID: 1917292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.
    Li T; Fujita Y; Tsuda Y; Miyazaki A; Ambo A; Sasaki Y; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
    J Med Chem; 2005 Jan; 48(2):586-92. PubMed ID: 15658871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.
    Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
    J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective opioid dipeptides.
    Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
    Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
    J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs.
    Gach K; do-Rego JC; Fichna J; Storr M; Delbro D; Toth G; Janecka A
    Peptides; 2010 Aug; 31(8):1617-24. PubMed ID: 20434497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W; Stoldt M; Schinke H
    J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T; Ro S; Goodman M
    Biochem Biophys Res Commun; 1991 Dec; 181(2):664-70. PubMed ID: 1661586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.
    Lee YS; Agnes RS; Badghisi H; Davis P; Ma SW; Lai J; Porreca F; Hruby VJ
    J Med Chem; 2006 Mar; 49(5):1773-80. PubMed ID: 16509592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel morphiceptin analogues modified in position 3 and their binding to mu-opioid receptors in experimental mammary adenocarcinoma.
    Janecka A; Fichna J; Wiercioch R; Mirowski M
    Bioorg Med Chem; 2003 Sep; 11(18):3855-60. PubMed ID: 12927845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid activities of morphiceptin-like peptides latent in various natural proteins.
    Shimohigashi Y; Sakaguchi K; Sakamoto H; Waki M; Costa T
    Pept Res; 1990; 3(5):216-23. PubMed ID: 1966866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.